Influenza News and Research

Latest Influenza News and Research

Millions of COVID-19 cases went undetected in the first six months of the pandemic, finds study

A new report published in the journal Science Translational Medicine estimates that potentially 16.8 million Americans were infected but not officially diagnosed with SARS-CoV-2 by July 2020. In addition, the results suggest there were nearly five undetected coronavirus cases for every diagnosed coronavirus infection in the first six months of the pandemic.

12 Jul 2021

Intranasal COVID-19 vaccine protects animals against lethal COVID-19 infection

In a new study assessing the potential of a single-dose, intranasal COVID-19 vaccine, a team from the University of Iowa and the University of Georgia found that the vaccine fully protects mice against lethal COVID-19 infection.

8 Jul 2021

Instant biosensor can detect COVID-19 variants even if someone is asymptomatic

RMIT University is collaborating with partners including Australian biomedical start-up Soterius on the biosensor, which can detect the presence of tiny amounts of the SARS-CoV-2 virus and its variants.

8 Jul 2021

Researchers discover how to artificially produce healthy mucus

Many people instinctively associate mucus with something disgusting, but in fact, it has incredibly many valuable functions for our health. It keeps track of our important intestinal flora and feeds the bacteria.

8 Jul 2021

Can memory T cell responses to seasonal coronaviruses protect against severe COVID-19?

In a recent study published in the journal Science Immunology, scientists have revealed that the presence of CD8+ T cells against conserved epitopes of seasonal coronaviruses is associated with mild coronavirus disease 2019 (COVID-19). These immune cells exhibit a memory phenotype and provide protection against severe disease.

7 Jul 2021

As covid vaccinations slow, parts of the US remain far behind 70% goal

July Fourth was not the celebration President Joe Biden had hoped for, as far as protecting more Americans with a coronavirus vaccine.

7 Jul 2021

COVID-19 vaccination may be stemming evolution of “fitter” SARS-CoV-2 variants

Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2021

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

A group of researchers recently discussed their findings that a group of plant flavonols and dihydroflavonols exhibit antiviral efficacy against both SARS-CoV-2 and HCoV-229E.

6 Jul 2021

Study explores the effects of SARS-CoV-2 (and other betacoronaviruses) on cellular mRNA processing

A new study has been released on the bioRxiv* preprint server, which deals with a comprehensive survey on alternative splicing concerning SARS-CoV-2 infection. This study has also included two other betacoronavirurses (SARS-CoV and MERS), a control set of unrelated viruses, and a bacterium, namely, Streptococcus pneumonia. The study findings suggest that several cellular parameters are affected owing to a betacoronavirus infection, which in turn affects some genes and invariably various biological functions.

6 Jul 2021

Developing a face mask that can detect COVID-19

A face mask has been developed that can detect COVID-19. News-Medical spoke to the researchers behind this idea to find out more about how it works.

6 Jul 2021

Phylogenetic network analysis reveals recombinant origin of the SARS-CoV-2 alpha (B.1.1.7) variant

Researchers from the U.S. recently used the phylogenetic network approach to analyze the origin of the VOC202012/01 (alpha) or the PANGO Lineage B.1.1.7 variant, which was first reported in U.K. in 2020 and soon spread to other countries. This study is published on the bioRxiv preprint server while the paper undergoes peer review.

5 Jul 2021

Researchers develop random priming amplification method for whole-genome sequencing of SARS-CoV-2 and H1N1

Researchers from the UK recently compared the performance of 4 different random priming amplification methods to recover SARS-CoV-2 RNA. In method 1 (H-P), the reverse transcriptase (RT) step included random hexamers, whereas, in methods 2-4, RT incorporated an octamer primer with a known tag. This study is published on the bioRxiv preprint server.

5 Jul 2021

Research pinpoints a molecular component responsible for modulating flu damage

New experimental data pinpoints a molecular component responsible for modulating the damage the flu can wreck on the lungs.

2 Jul 2021

Salivary markers of oxidative stress during severe COVID-19

An interesting study from researchers at the University of Sharjah, Sharjah, United Arab Emirates, presents evidence that an elevated level of expression of oxidant molecules may be correlated with severe infection and lung injury.

2 Jul 2021

What role did the SARS-CoV-2 delta variant play in India’s devastating second wave?

A detailed report, available on the preprint server medRxiv*, describes the various facets of the second wave that set it apart from the first. The report also contains the findings of an extended SIR model that explored the potential effects of intervention at various time points in the second wave.

2 Jul 2021

The use of flavonoids as antiviral agents against SARS-CoV-2

Researchers in Iran have undertaken a comprehensive review of flavonoids and their antiviral potential against SARS-CoV-2.

2 Jul 2021

Vaccines grown in eggs can lead to an off-target antibody response

Over years of studying antibody responses against the flu in the Wilson lab at the University of Chicago, researchers kept coming up with a strange finding: antibodies that seemed to bind not only to the flu virus but to every virus the lab could throw at them.

2 Jul 2021

Is there a link between circadian rhythms and COVID-19 severity?

This study showed that the time of day of SARS-CoV-2 infection could impact the severity of the viral infection and the host immune response.

1 Jul 2021

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

In a recently published article scientists have provided a detailed description of the utility of mannose-specific lectins in preventing coronavirus infections. They have specifically explained how mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of viral spike protein and how such interactions can be medically utilized to control coronavirus transmission.

1 Jul 2021

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

In new research from researchers in the USA and Australia peridomestic mammals, which live in and around human habitations, have been investigated to ascertain how SARS-CoV-2 can affect species external to, but in close proximity to, the human population.

1 Jul 2021

Influenza News and Research

Latest Influenza News and Research

Millions of COVID-19 cases went undetected in the first six months of the pandemic, finds study

Intranasal COVID-19 vaccine protects animals against lethal COVID-19 infection

Instant biosensor can detect COVID-19 variants even if someone is asymptomatic

Researchers discover how to artificially produce healthy mucus

Can memory T cell responses to seasonal coronaviruses protect against severe COVID-19?

As covid vaccinations slow, parts of the US remain far behind 70% goal

COVID-19 vaccination may be stemming evolution of “fitter” SARS-CoV-2 variants

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Study explores the effects of SARS-CoV-2 (and other betacoronaviruses) on cellular mRNA processing

Developing a face mask that can detect COVID-19

Phylogenetic network analysis reveals recombinant origin of the SARS-CoV-2 alpha (B.1.1.7) variant

Researchers develop random priming amplification method for whole-genome sequencing of SARS-CoV-2 and H1N1

Research pinpoints a molecular component responsible for modulating flu damage

Salivary markers of oxidative stress during severe COVID-19

What role did the SARS-CoV-2 delta variant play in India’s devastating second wave?

The use of flavonoids as antiviral agents against SARS-CoV-2

Vaccines grown in eggs can lead to an off-target antibody response

Is there a link between circadian rhythms and COVID-19 severity?

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in